- Home
- ALTG vs ZNTL Comparison
ALTG vs ZNTL Comparison
Compare ALTG & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- ZNTL
- Stock Information
- Founded
- ALTG 1984
- ZNTL 2014
- Country
- ALTG United States
- ZNTL United States
- Employees
- ALTG N/A
- ZNTL N/A
- Industry
- ALTG Industrial Machinery/Components
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- ALTG Industrials
- ZNTL Health Care
- Exchange
- ALTG Nasdaq
- ZNTL Nasdaq
- Market Cap
- ALTG 119.3M
- ZNTL 102.2M
- IPO Year
- ALTG N/A
- ZNTL 2020
- Fundamental
- Price
- ALTG $4.60
- ZNTL $1.23
- Analyst Decision
- ALTG Buy
- ZNTL Buy
- Analyst Count
- ALTG 3
- ZNTL 8
- Target Price
- ALTG $13.50
- ZNTL $8.53
- AVG Volume (30 Days)
- ALTG 126.7K
- ZNTL 752.0K
- Earning Date
- ALTG 05-07-2025
- ZNTL 05-20-2025
- Dividend Yield
- ALTG 5.01%
- ZNTL N/A
- EPS Growth
- ALTG N/A
- ZNTL N/A
- EPS
- ALTG N/A
- ZNTL N/A
- Revenue
- ALTG $1,858,000,000.00
- ZNTL $67,425,000.00
- Revenue This Year
- ALTG $3.54
- ZNTL N/A
- Revenue Next Year
- ALTG $3.40
- ZNTL N/A
- P/E Ratio
- ALTG N/A
- ZNTL N/A
- Revenue Growth
- ALTG N/A
- ZNTL N/A
- 52 Week Low
- ALTG $3.54
- ZNTL $1.01
- 52 Week High
- ALTG $12.09
- ZNTL $13.24
- Technical
- Relative Strength Index (RSI)
- ALTG 50.80
- ZNTL 38.08
- Support Level
- ALTG $4.13
- ZNTL $1.33
- Resistance Level
- ALTG $4.98
- ZNTL $1.32
- Average True Range (ATR)
- ALTG 0.30
- ZNTL 0.10
- MACD
- ALTG 0.06
- ZNTL -0.00
- Stochastic Oscillator
- ALTG 62.38
- ZNTL 8.22
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.